Platelet test for finding and tracking prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial studies a new blood test that looks at platelets (a part of your blood) to help find prostate cancer or keep track of it. You may join if you are a man over 40 with a suspicion of prostate cancer who has not been treated for it before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 40 or older.
- You have signs or a doctor's suspicion of prostate cancer (but no prior diagnosis).
- You have not been treated for prostate cancer before.
- You do not have a severe clotting disorder that cannot be reversed.
- You have not taken aspirin, ibuprofen, clopidogrel, or similar blood-thinning medications in the past 7 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new blood test to help decide if you need a prostate biopsy. It may help men with high PSA levels or an abnormal rectal exam avoid unnecessary procedures.
This study uses a new blood test to find DNA fragments that may show early signs of prostate cancer. It is for men with higher PSA levels who already need a prostate biopsy.
This study uses a simple blood test to look for microRNA patterns that may help spot prostate cancer earlier and avoid unnecessary biopsies. If you have elevated PSA or suspicious findings, this test might give more information about your risk.
This trial studies a blood test that looks for tumor DNA in men with high-risk or advanced prostate cancer. It may help doctors understand the cancer better and guide treatment decisions.
This study tests whether a new blood test called Proclarix can better predict which men actually have prostate cancer before they undergo a biopsy. If the test works well, it could help avoid unnecessary biopsies in the future.
This study checks whether certain blood markers can help predict how well people with prostate cancer will respond to therapy. It may help doctors choose the most effective treatment sooner by using information from your blood.
Hear when a new Prostate Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.